-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 14, the "2017 XIN Forum" hosted by Tsinghua University, Tel Aviv University of Israel and the Israeli Embassy in China was held at Tsinghua University. Under the theme of "Global Health and Sustainability", the Forum explores the current situation, opportunities and challenges of the global health industry.
"The biggest problem facing China's medical and health industry is that medical demand and supply do not match, and our current medical system is unable to meet the growing demand for medical and health care in society." Zhu Hengyuan, vice president of Tsinghua University's Institute of Global Industry 4.5, points out that "as the aging process accelerates, China's disease structure is already highly similar to that of developed countries." At the same time, as China moved from middle-income to high-income countries, the middle class put forward higher demands on the effectiveness, quality and experience of medical services, and the social medical demand structure showed a multi-level, diversified and dynamic trend, which brought unprecedented challenges to China's medical supply system.
Zhu Hengyuan, China's current medical service system can be divided into two parts: one is the established public medical service system, with basic and wide coverage as the principle, with public health care institutions as the main body, with government finance and basic medical insurance as the main source of health financing, according to the government approved pricing The provision of health services to the whole population is called the "safeguard rail", and the other is the competitive pricing of the health service system, which is based on the private health service (including private non-profit organizations), with commercial medical insurance and personal out-of-fund as the main source of financing, in response to the market demand. The safeguard rail occupies the absolute dominant position, but it is already overwhelmed, and the competition track is growing rapidly, but it is small in scale, scattered in structure and disorderly in management. He suggested that to seize the opportunity of upgrading the emerging medical needs and promote the development of the competitive track, once the competitive track grows to be able to bear a considerable amount of medical services, it can be for the reform of the safeguard rail to win the conversion space, a process known as the "two-track tug-of-war."
, the entry of business giants has made the competitive track more powerful. China Minsheng Investment Group, China's largest private investment group, officially entered the medical field in September 2016 to create a medical ecosystem. "Our strategy can be divided into three phases, the first stage is to accumulate high-quality medical assets to build the headquarters investment capacity, the second stage is to build the medical system, to build the headquarters resource integration and operational capacity, the third stage is to form a medical ecology, innovative business model, to help market-oriented medical ecological construction." Yang Wei, vice president of Zhongmin Medical, said.
"The main experience of China's past reforms is to take incremental reforms to promote the development of the stock through incremental reforms. The 'two-track tug-of-war' of the medical service system will drive the transformation and upgrading of the medical and health industry, affecting the pattern of the whole medical and health industry, including medical care, medical insurance, medicine, etc., and will be the biggest point of view of China's medical and health industry in the next ten years. If the 'new health care reform' can seize this historic window of opportunity, China's health care industry will show a magnificent picture of history. Zhu Hengyuan said. (Economic Reference Network)